Reata Pharmaceuticals Stock Price - RETA

129.00
0.14 (0.11%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Reata Pharmaceuticals Inc RETA NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 128.86 126.10 137.4264 134.91 128.86 00:00:03
Bid Price Ask Price Spread Spread % News
110.00 899.99 789.99 87.78% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,470 356,028 $ 130.18 $ 46,348,875 446,698 70.00 - 257.965
Last Trade Time Type Quantity Stock Price Currency
17:38:05 1 $ 129.00 USD

Reata Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.28B 33.23M $ -80.55M -9.54 - 32.93M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 9.00 0.90%

more financials information »

Reata Pharmaceuticals News

Date Time Source News Article
3/30/202016:05GlobeNewswire Inc.Reata Pharmaceuticals Provides Update on the Impact of the..
3/18/202014:21Edgar (US Regulatory)Unknown (sec Staff)
3/18/202014:21Edgar (US Regulatory)Unknown (sec Staff)
3/02/202015:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
2/26/202016:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)
2/19/202016:07Edgar (US Regulatory)Annual Report (10-k)
2/19/202016:04Edgar (US Regulatory)Current Report Filing (8-k)

Latest RETA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RETA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week143.18162.0449126.10144.17452,518-14.32-10.0%
1 Month191.47195.09113.01145.97487,313-62.61-32.7%
3 Months207.97257.965113.01186.84422,422-79.11-38.04%
6 Months74.02257.96573.435185.38500,42154.8474.09%
1 Year92.44257.96570.00154.47364,24336.4239.4%
3 Years22.77257.96519.3197.58273,445106.09465.92%
5 Years11.06257.96511.0390.54235,075117.801,065.1%

Reata Pharmaceuticals Description

Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.
Your Recent History
NASDAQ
RETA
Reata Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200405 08:30:22